Edwards Lifesciences Corporation Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Edwards Lifesciences Corporation (EW) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $82.71 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-04
- Edwards Lifesciences Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2013 was $71.48, a 17.55% decline from fiscal 2012.
- Edwards Lifesciences Corporation share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2012 was $86.70.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|
| 2026-06-30 | $82.71 10-Q · filed 2026-08-04 | ||
| 2025-09-30 | $74.78 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $74.64 10-Q · filed 2025-08-06 | ||
| 2024-09-30 | $85.94 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $85.86 10-Q · filed 2024-07-31 | ||
| 2023-09-30 | $88.45 10-Q · filed 2023-10-27 | ||
| 2023-06-30 | $88.72 10-Q · filed 2023-07-28 | ||
| 2022-09-30 | $105.18 10-Q · filed 2022-10-28 | ||
| 2022-06-30 | $106.14 10-Q · filed 2022-07-29 | ||
| 2021-09-30 | $93.74 10-Q · filed 2021-10-29 | ||
| 2021-06-30 | $85.24 10-Q · filed 2021-07-30 | ||
| 2020-09-30 | $72.84 10-Q · filed 2020-10-26 | ||
| 2020-06-30 | $72.82 10-Q · filed 2020-07-27 | ||
| 2016-09-30 | $105.38 10-Q · filed 2016-10-28 | ||
| 2016-06-30 | $105.39 10-Q · filed 2016-07-29 | ||
| 2015-09-30 | $132.31 10-Q · filed 2015-10-29 | ||
| 2015-06-30 | $130.89 10-Q · filed 2015-07-29 | ||
| 2013-12-31 | $71.48 10-K · filed 2014-02-28 | ||
| 2012-12-31 | $86.70 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |